378 related articles for article (PubMed ID: 14624765)
1. Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment.
Höybye C; Barkeling B; Espelund U; Petersson M; Thorén M
Growth Horm IGF Res; 2003 Dec; 13(6):322-7. PubMed ID: 14624765
[TBL] [Abstract][Full Text] [Related]
2. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
Höybye C
Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
[TBL] [Abstract][Full Text] [Related]
3. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome.
DelParigi A; Tschöp M; Heiman ML; Salbe AD; Vozarova B; Sell SM; Bunt JC; Tataranni PA
J Clin Endocrinol Metab; 2002 Dec; 87(12):5461-4. PubMed ID: 12466337
[TBL] [Abstract][Full Text] [Related]
4. Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader-Willi syndrome.
Haqq AM; Stadler DD; Rosenfeld RG; Pratt KL; Weigle DS; Frayo RS; LaFranchi SH; Cummings DE; Purnell JQ
J Clin Endocrinol Metab; 2003 Aug; 88(8):3573-6. PubMed ID: 12915638
[TBL] [Abstract][Full Text] [Related]
5. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
[TBL] [Abstract][Full Text] [Related]
6. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.
Goldstone AP; Holland AJ; Butler JV; Whittington JE
Int J Obes (Lond); 2012 Dec; 36(12):1564-70. PubMed ID: 22270375
[TBL] [Abstract][Full Text] [Related]
7. Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome.
Salehi P; Hsu I; Azen CG; Mittelman SD; Geffner ME; Jeandron D
Pediatr Obes; 2017 Jun; 12(3):221-228. PubMed ID: 27071367
[TBL] [Abstract][Full Text] [Related]
8. The growth hormone-insulin-like growth factor axis in adult patients with Prader Willi syndrome.
Höybye C; Frystyk J; Thorén M
Growth Horm IGF Res; 2003 Oct; 13(5):269-74. PubMed ID: 12932748
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of a normal meal-induced decrease in plasma ghrelin levels in children with Prader-Willi syndrome.
Bizzarri C; Rigamonti AE; Giannone G; Berardinelli R; Cella SG; Cappa M; Müller EE
Horm Metab Res; 2004 Mar; 36(3):164-9. PubMed ID: 15057669
[TBL] [Abstract][Full Text] [Related]
10. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome.
Haqq AM; Farooqi IS; O'Rahilly S; Stadler DD; Rosenfeld RG; Pratt KL; LaFranchi SH; Purnell JQ
J Clin Endocrinol Metab; 2003 Jan; 88(1):174-8. PubMed ID: 12519848
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone treatment improves body composition in adults with Prader-Willi syndrome.
Höybye C; Hilding A; Jacobsson H; Thorén M
Clin Endocrinol (Oxf); 2003 May; 58(5):653-61. PubMed ID: 12699450
[TBL] [Abstract][Full Text] [Related]
12. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
[TBL] [Abstract][Full Text] [Related]
13. Effect of Genotype and Previous GH Treatment on Adiposity in Adults With Prader-Willi Syndrome.
Coupaye M; Tauber M; Cuisset L; Laurier V; Bieth E; Lacorte JM; Oppert JM; Clément K; Poitou C
J Clin Endocrinol Metab; 2016 Dec; 101(12):4895-4903. PubMed ID: 27662437
[TBL] [Abstract][Full Text] [Related]
14. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
15. Metabolic profiling in Prader-Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone.
Irizarry KA; Bain J; Butler MG; Ilkayeva O; Muehlbauer M; Haqq AM; Freemark M
Clin Endocrinol (Oxf); 2015 Dec; 83(6):797-805. PubMed ID: 25736874
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development.
Haqq AM; Grambow SC; Muehlbauer M; Newgard CB; Svetkey LP; Carrel AL; Yanovski JA; Purnell JQ; Freemark M
Clin Endocrinol (Oxf); 2008 Dec; 69(6):911-20. PubMed ID: 18710462
[TBL] [Abstract][Full Text] [Related]
17. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome.
Kuppens RJ; Diène G; Bakker NE; Molinas C; Faye S; Nicolino M; Bernoux D; Delhanty PJ; van der Lely AJ; Allas S; Julien M; Delale T; Tauber M; Hokken-Koelega AC
Endocrine; 2015 Dec; 50(3):633-42. PubMed ID: 25989955
[TBL] [Abstract][Full Text] [Related]
18. Serum adiponectin levels in adults with Prader-Willi syndrome are independent of anthropometrical parameters and do not change with GH treatment.
Hoybye C; Bruun JM; Richelsen B; Flyvbjerg A; Frystyk J
Eur J Endocrinol; 2004 Oct; 151(4):457-61. PubMed ID: 15476445
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients.
Höybye C; Hilding A; Marcus C; Thorén M
Growth Horm IGF Res; 2005 Dec; 15(6):411-5. PubMed ID: 16230042
[TBL] [Abstract][Full Text] [Related]
20. Effects of Growth Hormone Treatment on Sleep-Related Parameters in Adults With Prader-Willi Syndrome.
Shukur HH; Hussain-Alkhateeb L; Farholt S; Nørregaard O; Jørgensen AP; Hoybye C
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3634-e3643. PubMed ID: 33950234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
